Probiotics in transition: Novel strategies

Trends in Biotechnology

Volumn 33, Issue 4, 2015, Pages 195-196

  Gosálbez, Luis ^a   Ramón, Daniel ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Bioactives; GMO; Postbiotics; Probiotics

Indexed keywords

BIOTECHNOLOGY;

BIOACTIVES; GENETICALLY MODIFIED; HEALTH CLAIMS; MICROBIAL PRODUCTS; MICROBIAL SPECIES; NOVEL STRATEGIES; POSTBIOTICS;

PROBIOTICS;

MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; PREBIOTIC AGENT; PROBIOTIC AGENT;

ANTIINFLAMMATORY ACTIVITY; BACTERIAL STRAIN; BACTERIAL VIABILITY; BIFIDOBACTERIACEAE; CLINICAL EFFECTIVENESS; DIET SUPPLEMENTATION; FOOD INTAKE; FOOD SAFETY; FUNCTIONAL FOOD; GENETICALLY MODIFIED FOOD; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INTESTINE FLORA; LACTIC ACID BACTERIUM; NOTE; PRIORITY JOURNAL; RISK REDUCTION; MICROFLORA;

HUMANS; MICROBIOTA; PROBIOTICS;

EID: 84940363979     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2015.01.006     Document Type: Note

References (12)

1. Suez J., et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 2014, 514:181-186.
2. Sample I. Artificial sweeteners may promote diabetes. Guardian 2014, 17 September.
3. Thaiss C.A., et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell 2014, 159:514-529.
4. Feltman R. Even the bacteria in your gut get jet lag. Washington Post 2014, 17 October.
5. Olivares M., et al. Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease. Br. J. Nutr. 2014, 112:30-40.
6. Jones M.L., et al. Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial. Eur. J. Clin. Nutr. 2012, 66:1234-1241.
7. Regulation EC No 1924/2006 of the European Parliaments and the Council of 20 December 2006 on nutrition and health claims made on foods. Official J. Eur. Union 2006, L404:9-25. European Commission.
8. Scientific opinion on the maintenance of the list of QPS biological agents intentionally added to food and feed. EFSA J. 2013, 11:3449. EFSA Panel on Biological Hazards (BIOHAZ).
9. US Food and Drug Administration (2014) GRAS Notices. Published online October 31, 2014. http://www.accessdata.fda.gov/scripts/fdcc/?set=GRASNotices.
10. Montané E., et al. Clinical trial with the food supplement Nyaditum resae: a new tool to reduce the risk of developing active tuberculosis (45th World Conference on Lung Health, Barcelona). Int. J. Tuberc. Lung Cancer 2014, 18(Suppl. 1):S427.
11. A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis (NCT00729872) 2008, ClinicalTrials gov, US National Institutes of Health. https://clinicaltrials.gov/ct2/show/NCT00729872.
12. Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck (NCT00938080) 2014, ClinicalTrials gov, US National Institutes of Health. https://clinicaltrials.gov/ct2/show/NCT00938080.